Catalyst Wire Dossier Catalyst Wire Dossier

ATTRUBY

Acoramidis hydrochloride · BridgeBio Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATTRUBY, covering 2024-11-22 to 2024-11-22. Get the full timeline:

Most recent: FDA Approved: ATTRUBY — Original Application (BridgeBio Pharma, Inc.)

See pricing